rs144848
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Polymorphic coding and noncoding variants were transmitted in each family's relatives with a frequency ranging from 42 to 100%, with similar rate for each SNP in mutated and nonmutated families with the only exception of BRCA1 K1183R significantly more frequent in mutated families (P = 0.004); conversely, this SNP and BRCA2 N372H, were more frequently present in breast cancer relatives belonging to families in which pathological BRCA mutations were not present.
|
20352487 |
2011 |
rs144848
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The BRCA2 372 HH genotype defined by the BRCA2 N372H nonconservative amino acid substitution polymorphism was recently reported to be associated with a small increased risk of breast cancer.
|
12471628 |
2003 |
rs144848
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Previous association studies of breast cancer and BRCA2 N372H and functional observations for APEX D148E ran counter to our findings of decreased risks.
|
15113441 |
2004 |
rs1555281715
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1555283256
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1555287766
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs15869
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Gene-reproductive factors interactions analysis revealed that rs15869 together with age at menarche and number of pregnancy could increase the risk of BC by 2.39-fold and TT genotype (OR 0.316; 95% CI 0.130-0.767) of rs8176318 had a significant association with progesterone receptor status in BC patients.
|
27807724 |
2016 |
rs1799944
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Carriers of the BRCA2 rs1799944 variant (991 Asp) were found to have an increased risk of breast cancer (OR = 1.41, 95% CI 1.08-1.83, P = 0.01) with P (trend) = 0.0076.
|
18553220 |
2009 |
rs1799955
|
|
|
0.010 |
GeneticVariation |
BEFREE |
However, both SNPs, BRCA2 Ser2414Ser (7242A > G) and Ser455Ser (1365A > G), showed no association with breast cancer risk.
|
19229607 |
2009 |
rs1801426
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our study confirmed BRCA2 p.Ile3412Val is presented in >2% of unaffected women and is likely benign, and BRCA2 p.Ala1996Thr which is predicted to be likely pathogenic by in-silico models is presented in 2% of healthy Indian women suggesting that it may not be associated with breast cancer risk.
|
28222693 |
2017 |
rs1801439
|
|
|
0.010 |
GeneticVariation |
BEFREE |
However, both SNPs, BRCA2 Ser2414Ser (7242A > G) and Ser455Ser (1365A > G), showed no association with breast cancer risk.
|
19229607 |
2009 |
rs206340
|
|
|
0.010 |
GeneticVariation |
BEFREE |
These results could be explained on the basis of a single marker in intron 24 (SNP 42: rs206340) that was correlated with these haplotypes and the homozygous state was associated with a significantly increased risk of breast cancer (AA versus GG genotypes: OR=1.59, 95% CI, 1.18-2.16; nominal P=0.005).
|
15317758 |
2004 |
rs276174853
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs276174900
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28897706
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs28897708
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.
|
9609997 |
1998 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
BRCA2 T2722R is a deleterious allele that causes exon skipping.
|
12145750 |
2002 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Germline brca2 sequence variants in patients with ocular melanoma.
|
10399947 |
1999 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
BRCA2 germline mutations in male breast cancer patients in the Polish population.
|
11139248 |
2001 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
|
12938098 |
2003 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.
|
15172753 |
2004 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).
|
11241844 |
2001 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
|
9654203 |
1998 |
rs28897716
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
|
11948477 |
2002 |